CNMD vs IRTC Stock Comparison

CNMD currently leads IRTC in this stock comparison, with AIQ scores of 71 vs 44. The clearest difference is value.

Market data as of Nov 18, 2026 market close· AIQ score gap 27 points
CNMD
Healthcare
vs
IRTC
Healthcare
CNMD
CONMED Corporation
Leads
Price
$48.01
Day move
-0.79%
AIQ Score
71/100
Best edge
Value
Sector
Healthcare
IRTC
iRhythm Technologies, Inc.
Price
$94.87
Day move
+5.8%
AIQ Score
44/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between CNMD and IRTC?

CNMD leads the current stock comparison as CONMED Corporation, with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

CONMED Corporation vs iRhythm Technologies, Inc.

Data as of Nov 18, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

CNMD leads

CNMD leads by 27 AIQ points, primarily on Value and Momentum, and the lead has widened from 17 points over 30 sessions. Wall Street currently favors IRTC on target upside.

Stable: 5 of 6 evidence groups support CNMD, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 5 of 6Comparison trend: Strengthening
CNMD

CONMED Corporation

Leads
AIQ Score
71/100
AIQ Edge Score
9/10
IRTC

iRhythm Technologies, Inc.

AIQ Score
44/100
AIQ Edge Score
3/10

The Algovestiq AIQ Score currently favors CNMD over IRTC, 71 versus 44 as of Nov 18, 2026. CNMD's advantage is driven primarily by stronger value and momentum. CNMD also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors IRTC. 5 of 6 covered evidence groups favor CNMD today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. CNMD lead: Strengthening — the AIQ differential moved from 17 to 27 points over 30 sessions. CNMD leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare CONMED Corporation and iRhythm Technologies, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

CNMD
-65.1%
IRTC
-1.2%

Total return comparison

Growth of $10,000, distributions reinvested

CNMD $3,490 · IRTC $9,883

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare CNMD and IRTC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CNMD advantage
0
IRTC advantage
  • Value84 vs 43
    CNMD +41
  • Momentum74 vs 34
    CNMD +40
  • Risk Resilience58 vs 44
    CNMD +14
  • Quality66 vs 58
    CNMD +8

5 of 6 evidence groups favor CNMD. CNMD’s edge is concentrated in value and momentum.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

CNMD-1 AIQ

Largest factor move: Momentum -2

No signal started or stopped since the prior session; its 7 active signals are unchanged.

IRTC0 AIQ

Largest factor move: Value -1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

CNMD's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — CNMD and IRTC both carry a full feed there.

The central trade-off

CNMD (CONMED Corporation): the stronger current systematic profile, led by value and momentum.

IRTC (iRhythm Technologies, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 121.5% against 62.2%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

CNMD

CNMD on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CNMD

CNMD on combined revenue and EPS growth.

Value

CNMD

CNMD on the peer-relative Value factor, by 41 points.

Momentum

CNMD

CNMD on the Momentum factor, by 40 points.

Lower downside

CNMD

CNMD on Risk Resilience, by 14 points.

Analyst upside

IRTC

IRTC on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors CNMD, analyst targets favor IRTC. That disagreement is the most useful thing on this page.

MeasureCNMDIRTCNote
Implied upside to target+4.1%+86.6%IRTC has more room
Target dispersion0%+26%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering717Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

5 of 6 covered evidence groups favor CNMD. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreCNMD71 vs 44
FundamentalsCNMDon balancerevenue growth -2.3% vs -1.2%; EPS growth -14.3% vs -89%; TTM ROE 1.9% vs -16.9%; gross margin 57.2% vs 72.3%; operating margin 12.1% vs -4.5% — CNMD takes 3 of 5 decided legs, not all of them
ValuationCNMDValue 84 vs 43
TechnicalsCNMDPrice vs 50-day 1.8% vs -15.1%; vs 200-day 20.7% vs -23.1%
Risk ResilienceCNMDRisk Resilience 58 vs 44
Analyst expectationsIRTCTarget upside 4.1% vs 86.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CNMD and IRTC and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 27 points. (supports the conclusion holding)
  • 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CNMD.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

CNMD lead: Strengthening — the AIQ differential moved from 17 to 27 points over 30 sessions.

Jun 1CNMD leads above the line · IRTC leads belowNov 18
Today
CNMD +27
71 vs 44
7 sessions ago
CNMD +20
73 vs 53
30 sessions ago
CNMD +17
71 vs 54
90 sessions ago
CNMD +20
69 vs 49

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CNMDConflicted

4 bullish / 1 bearish / 2 neutral, conflicted

Only CNMD

  • Golden Cross Active — bullish, trend, long horizon (12.55%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.48x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
IRTC

0 bullish / 3 bearish / 1 neutral

Only IRTC

  • Death Cross Active — bearish, trend, long horizon (7.01%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

CNMD leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CNMDConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.79%, AIQ -1 points).

IRTCNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +5.8%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1IRTC closes the Value gap — currently 41 points behind, the largest single contributor to CNMD's edge.
  2. 2IRTC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3CNMD's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

CNMD leads on balance
MetricCNMDIRTC
Revenue growth (YoY)-2.3%-1.2%
EPS growth (YoY)-14.3%-89%
Gross margin57.2%72.3%
Operating margin12.1%-4.5%
Return on equity (TTM)1.9%-16.9%
Debt to equity0.774.1

Performance

CNMD leads 5 of 6 windows
MetricCNMDIRTC
1 week (5 sessions)-1.8%1.9%
1 month (20 sessions)8.3%-15.4%
3 months (63 sessions)2.7%-21.4%
6 months (126 sessions)42.5%-19.4%
Year to date24.6%-48.2%
1 year (252 sessions)16.1%-48.7%

Technicals

CNMD has the stronger structure
MetricCNMDIRTC
RSI (14)56.835.3
ADX (14)23.332
Price vs 50-day1.8%-15.1%
Price vs 200-day20.7%-23.1%
Volatility (1M, annualized)62.2%121.5%

Risk

CNMD is the more resilient
MetricCNMDIRTC
Beta0.790.5
Sharpe ratio0.48-0.91
Sortino ratio0.76-1.11
Max drawdown-30.3%-54.5%
Current drawdown-5.7%-51.4%
Annualized volatility47%54%
Value at risk (95%)-4%-4.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CNMD or IRTC?

On the Algovestiq AIQ Score, CNMD is the stronger of the two as of Nov 18, 2026, scoring 71 against IRTC's 44. The edge comes from value and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CNMD or IRTC the better buy right now?

CNMD carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor CNMD over IRTC?

The composite weights Quality, Value, Momentum and Risk Resilience. CNMD leads Value by 41 points; CNMD leads Momentum by 40 points; CNMD leads Risk Resilience by 14 points. CNMD leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by IRTC simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, CNMD or IRTC?

Analyst price targets imply +4.1% upside for CNMD and +86.6% for IRTC, so the Street currently favors IRTC. That points the opposite way to the AIQ Score, which favors CNMD. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CNMD or IRTC?

CNMD is the better-valued of the two on the peer-relative Value factor. CNMD on the peer-relative Value factor, by 41 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CNMD or IRTC?

CNMD on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CNMD or IRTC?

CNMD on the Momentum factor, by 40 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CNMD or IRTC?

CNMD is the more resilient of the two, so the other name carries the higher downside risk. CNMD on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CNMD more profitable than IRTC?

The profitability evidence is mixed: gross margin 57.2% vs 72.3%; operating margin 12.1% vs -4.5%; ttm roe 1.9% vs -16.9%. CNMD leads on two measures and IRTC on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is CNMD's lead over IRTC getting stronger or weaker?

CNMD lead: Strengthening — the AIQ differential moved from 17 to 27 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.

What would change the CNMD vs IRTC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IRTC closes the Value gap — currently 41 points behind, the largest single contributor to CNMD's edge; IRTC's Death Cross Active resolves — a bearish trend rule currently active against it; CNMD's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about CNMD and IRTC?

CNMD: 4 bullish / 1 bearish / 2 neutral, conflicted. IRTC: 0 bullish / 3 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CNMD is Golden Cross Active (bullish, long horizon). On IRTC it is Death Cross Active (bearish, long horizon).

Compare CNMD and IRTC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.